- $3.44bn
- $3.37bn
- $582.01m
Annual cashflow statement for Exponent, fiscal year end - January 2nd, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 30th | 2023 December 29th | 2025 January 3rd | 2026 January 2nd | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 53 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 101 | 102 | 100 | 109 | 106 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 21.2 | 23.4 | 23.6 | 27.7 | 26.8 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.67 | -31.7 | -5.57 | 1.46 | -1.2 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 125 | 93.8 | 127 | 145 | 132 |
| Capital Expenditures | -6.83 | -12 | -16.4 | -6.94 | -9.39 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 45 | 0 | 0 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 38.2 | -12 | -16.4 | -6.94 | -9.39 |
| Financing Cash Flow Items | -15.7 | -12.9 | -9.94 | -6.92 | -4.17 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -62.8 | -216 | -86 | -65.1 | -160 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 100 | -136 | 25.7 | 71.8 | -37 |